AgomAb director Epstein buys 10,000 shares of AGMB
AgomAb Therapeutics NV director David R Epstein reported purchasing 10,000 shares of AGMB at $8.64 per share, for about $86,350, during Oct. 5–6, 2026.
AgomAb Therapeutics NV director David R Epstein reported purchasing 10,000 shares of AGMB at $8.64 per share, for about $86,350, during Oct. 5–6, 2026.